Position in NBIX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,330,085
+$103,354 QoQ
Shares Held
17,687
+12.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,208,250 across 29 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,687 | $2,779,297 | |
| 2 | ALKS |
Alkermes plc.
|
77,769 | $2,749,911 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
17,687 | $2,330,085 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
158,462 | $1,508,558 | |
| 5 | ZTS |
Zoetis Inc.
|
6,653 | $786,451 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
22,305 | $533,758 | |
| 7 | HLN |
Haleon plc
|
50,589 | $506,395 | |
| 8 | VTRS |
Viatris Inc
|
29,453 | $397,910 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,330,085 | 17,687 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,226,731 | 15,700 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,975,006 | 14,069 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,227,980 | 17,726 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,439,061 | 22,053 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,965,189 | 21,723 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,353,823 | 29,108 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,347,721 | 24,317 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,918,743 | 13,912 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,012,106 | 15,271 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,800,787 | 16,007 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,777,932 | 18,854 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,641,585 | 16,218 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,658,782 | 13,888 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,442,650 | 13,583 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,373,980 | 14,095 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,460,437 | 15,578 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,471,226 | 17,274 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,909,568 | 19,910 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,057,636 | 21,143 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,098,655 | 21,580 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,824,984 | 19,040 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,666,645 | 17,332 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,510,638 | 20,579 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,497,747 | 17,305 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||